Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy

Dominik M. Haddad; Sven Vilain; Melissa Vos; Giovanni Esposito; Samer Matta; Vera M. Kalscheuer; Katleen Craessaerts; Maarten Leyssen; Rafaella M.P. Nascimento; Angela M. Vianna-Morgante; Bart DeStrooper; Hilde VanEsch; Vanessa A. Morais; Patrik Verstreken

doi:10.1016/j.molcel.2013.04.012

Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy

Dominik M. Haddad, Sven Vilain, Melissa Vos, Giovanni Esposito, Samer Matta, Vera M. Kalscheuer, Katleen Craessaerts, Maarten Leyssen, Rafaella M.P. Nascimento, Angela M. Vianna-Morgante, Bart DeStrooper, Hilde VanEsch, Vanessa A. Morais^*, Patrik Verstreken

^*Korrespondierende/r Autor/-in für diese Arbeit

Institut für Neurogenetik

82 Zitate (Scopus)

Abstract

The prevalence of intellectual disability is around 3%; however, the etiology of the disease remains unclear in most cases. We identified a series of patients with X-linked intellectual disability presenting mutations in the Rad6a (Ube2a) gene, which encodes for an E2 ubiquitin-conjugating enzyme. Drosophila deficient for dRad6 display defective synaptic function as a consequence of mitochondrial failure. Similarly, mouse mRad6a (Ube2a) knockout and patient-derived hRad6a (Ube2a) mutant cells show defective mitochondria. Using invitro and invivo ubiquitination assays, we show that RAD6A acts as an E2 ubiquitin-conjugating enzyme that, in combination with an E3 ubiquitin ligase such as Parkin, ubiquitinates mitochondrial proteins to facilitate the clearance of dysfunctional mitochondria in cells. Hence, we identify RAD6A as a regulator of Parkin-dependent mitophagy and establish a critical role for RAD6A in maintaining neuronal function.

Originalsprache	Englisch
Zeitschrift	Molecular Cell
Jahrgang	50
Ausgabenummer	6
Seiten (von - bis)	831-843
Seitenumfang	13
ISSN	1097-2765
DOIs	https://doi.org/10.1016/j.molcel.2013.04.012
Publikationsstatus	Veröffentlicht - 27.06.2013

Fördermittel

We thank the Bloomington and VDRC stock centers; Kyoung Sang Cho, Willy Baarends, and Konstanze Winklhofer for reagents; and Bassem Hassan, Wim Vandenberghe, and members of the Verstreken and De Strooper labs for comments. V.M.K. is financed by a grant of the German Ministry of Education and Research through the MRNET and by the Project GENCODYS (241995), which is funded by the European Union Framework Program 7 (FP7); S.V. and M.L. are supported by an FWO postdoctoral fellowship; and M.V. is supported by an IWT predoctoral fellowship and a PDM postdoctoral fellowship by the research fund KU Leuven. Support to P.V. was provided by a Marie Curie Excellence Grant (MEXT-CT-2006-042267), an ERC Starting Grant (260678), the Research Foundation Flanders (FWO grants G053913, G079013, G095511, and G074709), a Methusalem grant of the Flemish Government, the Francqui Foundation, the Hercules Foundation (AKUL/09/037), the Instutuut voor Wetenschap en Technologie (IWT), the Interuniversity Attraction Pole program by BELSPO (IAP P7/16 NEUROBRAINNET), the research fund KU Leuven (OT Start, GOA/13/017), and VIB.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.1016/j.molcel.2013.04.012

Weitere Links

Link to publication in Scopus

Zitieren

Haddad, D. M., Vilain, S., Vos, M., Esposito, G., Matta, S., Kalscheuer, V. M., Craessaerts, K., Leyssen, M., Nascimento, R. M. P., Vianna-Morgante, A. M., DeStrooper, B., VanEsch, H., Morais, V. A., & Verstreken, P. (2013). Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy. Molecular Cell, 50(6), 831-843. https://doi.org/10.1016/j.molcel.2013.04.012

@article{f64d8cef0eec40b38c41923ffe1cbf7b,

title = "Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy",

abstract = "The prevalence of intellectual disability is around 3\%; however, the etiology of the disease remains unclear in most cases. We identified a series of patients with X-linked intellectual disability presenting mutations in the Rad6a (Ube2a) gene, which encodes for an E2 ubiquitin-conjugating enzyme. Drosophila deficient for dRad6 display defective synaptic function as a consequence of mitochondrial failure. Similarly, mouse mRad6a (Ube2a) knockout and patient-derived hRad6a (Ube2a) mutant cells show defective mitochondria. Using invitro and invivo ubiquitination assays, we show that RAD6A acts as an E2 ubiquitin-conjugating enzyme that, in combination with an E3 ubiquitin ligase such as Parkin, ubiquitinates mitochondrial proteins to facilitate the clearance of dysfunctional mitochondria in cells. Hence, we identify RAD6A as a regulator of Parkin-dependent mitophagy and establish a critical role for RAD6A in maintaining neuronal function.",

author = "Haddad, \{Dominik M.\} and Sven Vilain and Melissa Vos and Giovanni Esposito and Samer Matta and Kalscheuer, \{Vera M.\} and Katleen Craessaerts and Maarten Leyssen and Nascimento, \{Rafaella M.P.\} and Vianna-Morgante, \{Angela M.\} and Bart DeStrooper and Hilde VanEsch and Morais, \{Vanessa A.\} and Patrik Verstreken",

note = "Funding Information: We thank the Bloomington and VDRC stock centers; Kyoung Sang Cho, Willy Baarends, and Konstanze Winklhofer for reagents; and Bassem Hassan, Wim Vandenberghe, and members of the Verstreken and De Strooper labs for comments. V.M.K. is financed by a grant of the German Ministry of Education and Research through the MRNET and by the Project GENCODYS (241995), which is funded by the European Union Framework Program 7 (FP7); S.V. and M.L. are supported by an FWO postdoctoral fellowship; and M.V. is supported by an IWT predoctoral fellowship and a PDM postdoctoral fellowship by the research fund KU Leuven. Support to P.V. was provided by a Marie Curie Excellence Grant (MEXT-CT-2006-042267), an ERC Starting Grant (260678), the Research Foundation Flanders (FWO grants G053913, G079013, G095511, and G074709), a Methusalem grant of the Flemish Government, the Francqui Foundation, the Hercules Foundation (AKUL/09/037), the Instutuut voor Wetenschap en Technologie (IWT), the Interuniversity Attraction Pole program by BELSPO (IAP P7/16 NEUROBRAINNET), the research fund KU Leuven (OT Start, GOA/13/017), and VIB. ",

year = "2013",

month = jun,

day = "27",

doi = "10.1016/j.molcel.2013.04.012",

language = "English",

volume = "50",

pages = "831--843",

journal = "Molecular Cell",

issn = "1097-2765",

publisher = "Cell Press",

number = "6",

}

Haddad, DM, Vilain, S, Vos, M, Esposito, G, Matta, S, Kalscheuer, VM, Craessaerts, K, Leyssen, M, Nascimento, RMP, Vianna-Morgante, AM, DeStrooper, B, VanEsch, H, Morais, VA & Verstreken, P 2013, 'Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy', Molecular Cell, Jg. 50, Nr. 6, S. 831-843. https://doi.org/10.1016/j.molcel.2013.04.012

TY - JOUR

T1 - Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy

AU - Haddad, Dominik M.

AU - Vilain, Sven

AU - Vos, Melissa

AU - Esposito, Giovanni

AU - Matta, Samer

AU - Kalscheuer, Vera M.

AU - Craessaerts, Katleen

AU - Leyssen, Maarten

AU - Nascimento, Rafaella M.P.

AU - Vianna-Morgante, Angela M.

AU - DeStrooper, Bart

AU - VanEsch, Hilde

AU - Morais, Vanessa A.

AU - Verstreken, Patrik

N1 - Funding Information: We thank the Bloomington and VDRC stock centers; Kyoung Sang Cho, Willy Baarends, and Konstanze Winklhofer for reagents; and Bassem Hassan, Wim Vandenberghe, and members of the Verstreken and De Strooper labs for comments. V.M.K. is financed by a grant of the German Ministry of Education and Research through the MRNET and by the Project GENCODYS (241995), which is funded by the European Union Framework Program 7 (FP7); S.V. and M.L. are supported by an FWO postdoctoral fellowship; and M.V. is supported by an IWT predoctoral fellowship and a PDM postdoctoral fellowship by the research fund KU Leuven. Support to P.V. was provided by a Marie Curie Excellence Grant (MEXT-CT-2006-042267), an ERC Starting Grant (260678), the Research Foundation Flanders (FWO grants G053913, G079013, G095511, and G074709), a Methusalem grant of the Flemish Government, the Francqui Foundation, the Hercules Foundation (AKUL/09/037), the Instutuut voor Wetenschap en Technologie (IWT), the Interuniversity Attraction Pole program by BELSPO (IAP P7/16 NEUROBRAINNET), the research fund KU Leuven (OT Start, GOA/13/017), and VIB.

PY - 2013/6/27

Y1 - 2013/6/27

N2 - The prevalence of intellectual disability is around 3%; however, the etiology of the disease remains unclear in most cases. We identified a series of patients with X-linked intellectual disability presenting mutations in the Rad6a (Ube2a) gene, which encodes for an E2 ubiquitin-conjugating enzyme. Drosophila deficient for dRad6 display defective synaptic function as a consequence of mitochondrial failure. Similarly, mouse mRad6a (Ube2a) knockout and patient-derived hRad6a (Ube2a) mutant cells show defective mitochondria. Using invitro and invivo ubiquitination assays, we show that RAD6A acts as an E2 ubiquitin-conjugating enzyme that, in combination with an E3 ubiquitin ligase such as Parkin, ubiquitinates mitochondrial proteins to facilitate the clearance of dysfunctional mitochondria in cells. Hence, we identify RAD6A as a regulator of Parkin-dependent mitophagy and establish a critical role for RAD6A in maintaining neuronal function.

AB - The prevalence of intellectual disability is around 3%; however, the etiology of the disease remains unclear in most cases. We identified a series of patients with X-linked intellectual disability presenting mutations in the Rad6a (Ube2a) gene, which encodes for an E2 ubiquitin-conjugating enzyme. Drosophila deficient for dRad6 display defective synaptic function as a consequence of mitochondrial failure. Similarly, mouse mRad6a (Ube2a) knockout and patient-derived hRad6a (Ube2a) mutant cells show defective mitochondria. Using invitro and invivo ubiquitination assays, we show that RAD6A acts as an E2 ubiquitin-conjugating enzyme that, in combination with an E3 ubiquitin ligase such as Parkin, ubiquitinates mitochondrial proteins to facilitate the clearance of dysfunctional mitochondria in cells. Hence, we identify RAD6A as a regulator of Parkin-dependent mitophagy and establish a critical role for RAD6A in maintaining neuronal function.

UR - https://www.scopus.com/pages/publications/84880807019

U2 - 10.1016/j.molcel.2013.04.012

DO - 10.1016/j.molcel.2013.04.012

M3 - Journal articles

C2 - 23685073

AN - SCOPUS:84880807019

SN - 1097-2765

VL - 50

SP - 831

EP - 843

JO - Molecular Cell

JF - Molecular Cell

IS - 6

ER -

Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy

Abstract

Fördermittel

UN SDGs

Dokumente

Weitere Links

Fingerprint

Zitieren